NO20016151D0 - Fremstilling av substituerte piperidin-4-oner - Google Patents

Fremstilling av substituerte piperidin-4-oner

Info

Publication number
NO20016151D0
NO20016151D0 NO20016151A NO20016151A NO20016151D0 NO 20016151 D0 NO20016151 D0 NO 20016151D0 NO 20016151 A NO20016151 A NO 20016151A NO 20016151 A NO20016151 A NO 20016151A NO 20016151 D0 NO20016151 D0 NO 20016151D0
Authority
NO
Norway
Prior art keywords
ones
preparation
substituted piperidin
piperidin
substituted
Prior art date
Application number
NO20016151A
Other languages
English (en)
Norwegian (no)
Other versions
NO20016151L (no
Inventor
John Robert Rizzo
Michael Alexander Staszak
Tony Yantao Zhang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20016151L publication Critical patent/NO20016151L/no
Publication of NO20016151D0 publication Critical patent/NO20016151D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/02Preparation by ring-closure or hydrogenation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20016151A 1999-06-29 2001-12-17 Fremstilling av substituerte piperidin-4-oner NO20016151D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14147899P 1999-06-29 1999-06-29
PCT/US2000/015029 WO2001000577A2 (en) 1999-06-29 2000-06-13 Preparation of substituted piperidin-4-ones

Publications (2)

Publication Number Publication Date
NO20016151L NO20016151L (no) 2001-12-17
NO20016151D0 true NO20016151D0 (no) 2001-12-17

Family

ID=22495854

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016151A NO20016151D0 (no) 1999-06-29 2001-12-17 Fremstilling av substituerte piperidin-4-oner

Country Status (23)

Country Link
US (1) US6538136B1 (cs)
EP (1) EP1196382A2 (cs)
JP (1) JP2003522122A (cs)
KR (1) KR20020015068A (cs)
CN (1) CN1356982A (cs)
AU (1) AU770759B2 (cs)
BR (1) BR0011996A (cs)
CA (1) CA2370491A1 (cs)
CO (1) CO5200762A1 (cs)
CZ (1) CZ20014548A3 (cs)
EA (1) EA200200101A1 (cs)
EG (1) EG22530A (cs)
HK (1) HK1045309A1 (cs)
HU (1) HUP0201642A3 (cs)
IL (1) IL146339A0 (cs)
MX (1) MXPA01012727A (cs)
NO (1) NO20016151D0 (cs)
PE (1) PE20010300A1 (cs)
PL (1) PL364868A1 (cs)
SK (1) SK19012001A3 (cs)
SV (1) SV2002000111A (cs)
WO (1) WO2001000577A2 (cs)
ZA (1) ZA200109206B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070026396A (ko) 2004-01-30 2007-03-08 베이징 투올린 메디슨 사이언스 앤드 테크놀로지 컴파니 리미티드 마라스미우스 안드로사세우스 L.es Fr 추출물,피페리돈 유도체 및 항고혈압제로서의 그 용도
US7738568B2 (en) 2004-06-03 2010-06-15 Silicon Laboratories Inc. Multiplexed RF isolator
US7447492B2 (en) 2004-06-03 2008-11-04 Silicon Laboratories Inc. On chip transformer isolator
US7902627B2 (en) 2004-06-03 2011-03-08 Silicon Laboratories Inc. Capacitive isolation circuitry with improved common mode detector
US7302247B2 (en) 2004-06-03 2007-11-27 Silicon Laboratories Inc. Spread spectrum isolator
US8441325B2 (en) 2004-06-03 2013-05-14 Silicon Laboratories Inc. Isolator with complementary configurable memory
US8198951B2 (en) 2004-06-03 2012-06-12 Silicon Laboratories Inc. Capacitive isolation circuitry
US7821428B2 (en) 2004-06-03 2010-10-26 Silicon Laboratories Inc. MCU with integrated voltage isolator and integrated galvanically isolated asynchronous serial data link
US8049573B2 (en) 2004-06-03 2011-11-01 Silicon Laboratories Inc. Bidirectional multiplexed RF isolator
US8451032B2 (en) 2010-12-22 2013-05-28 Silicon Laboratories Inc. Capacitive isolator with schmitt trigger
EP3293888B1 (en) 2016-09-13 2020-08-26 Allegro MicroSystems, LLC Signal isolator having bidirectional communication between die
US11115244B2 (en) 2019-09-17 2021-09-07 Allegro Microsystems, Llc Signal isolator with three state data transmission

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2883387A (en) * 1959-04-21 Chjch
DE510184C (de) * 1927-06-03 1930-10-16 Carl Mannich Dr Verfahren zur Darstellung von 2, 6-Dimethyl-4-ketopiperidin-3, 5-dicarbonsaeureestern
FR2717803B1 (fr) * 1994-03-25 1996-06-21 Meram Lab Dérivés substitués d'hétérocycles azotés et leurs isomères, actifs sur le système nerveux central, procédé d'obtention et compositions pharmaceutiques les contenant.
CA2336117A1 (en) * 1998-06-30 2000-01-06 Sidney Xi Liang Piperidine derivatives having effects on serotonin related systems

Also Published As

Publication number Publication date
AU5453500A (en) 2001-01-31
WO2001000577A2 (en) 2001-01-04
US6538136B1 (en) 2003-03-25
JP2003522122A (ja) 2003-07-22
MXPA01012727A (es) 2002-07-02
EP1196382A2 (en) 2002-04-17
EA200200101A1 (ru) 2002-06-27
CO5200762A1 (es) 2002-09-27
NO20016151L (no) 2001-12-17
KR20020015068A (ko) 2002-02-27
HUP0201642A3 (en) 2002-11-28
HUP0201642A2 (en) 2002-09-28
BR0011996A (pt) 2002-03-05
PE20010300A1 (es) 2001-03-07
PL364868A1 (en) 2004-12-27
CA2370491A1 (en) 2001-01-04
CN1356982A (zh) 2002-07-03
SV2002000111A (es) 2002-01-23
ZA200109206B (en) 2003-05-28
WO2001000577A3 (en) 2002-01-24
CZ20014548A3 (cs) 2002-04-17
SK19012001A3 (sk) 2002-06-04
IL146339A0 (en) 2002-07-25
AU770759B2 (en) 2004-03-04
HK1045309A1 (zh) 2002-11-22
EG22530A (en) 2003-03-31

Similar Documents

Publication Publication Date Title
PT1210113E (pt) Composicoes de vacinas de combinacao
PT1162973E (pt) Preparacao de cilostazole
NO20015017D0 (no) Fremgangsmåte for fremstilling av citalopram
PT1237827E (pt) Preparacao de acelerador de betao
NO20013945L (no) Fremstilling av isoflavonderivater
NO20030134D0 (no) Fremstilling av olefinderivater
NO20010318L (no) Fremgangsmåte for fremstilling av Citalopram
NO20010319D0 (no) Fremgangsmåte for fremstilling av Citalopram
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
ID30233A (id) Antibiotika ketolida
PT1150966E (pt) Metodo de preparacao de 5-cianoftalido
EE200200150A (et) Preparaat
DE60019960D1 (de) Herstellung von isobutencopolymere
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
NO20015505D0 (no) Fremstilling av komplekse karbohydrater
NO20025423D0 (no) FremgangsmÕte for fremstilling av Citalopram
PT1322592E (pt) Derivados substituidos de 1-aminobutan-3-ol
DE60016608D1 (de) Herstellung von sulfonylimin-verbindungen
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
PT1175417E (pt) Compostos substituidos de benzolactamas
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
NO20016030D0 (no) Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin
NO20022446D0 (no) Etere av O-desmetyl-venlafaxine
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
NO20020327D0 (no) Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application